ClassID:

21647

A61K2300/00 - page 36 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#10501
20100291246
2010-11-18

Anti-infection P-compound™

#10502
20100291242
2010-11-18

ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS

#10503
20100291240
2010-11-18

Method to stabilize a dietary supplement to facilitate joint health in humans

#10504
20100291238
2010-11-18

Appetite suppressant product and method

#10505
20100291235
2010-11-18

COMPOSITION FOR TREATING STERILE INFLAMMATION

#10506
20100291234
2010-11-18

Compositions and methods for treating inflammatory arthritis

#10507
20100291233
2010-11-18

TREATMENT OF NEUROLOGICAL DISORDERS

#10508
20100291228
2010-11-18

SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS

#10509
20100291227
2010-11-18

LIP LUBRICANT AND METHOD OF LUBRICATING THE LIPS

#10510
20100291221
2010-11-18

Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation

#10511
20100291212
2010-11-18

Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use

#10512
20100291209
2010-11-18

ORGANIC COMPOUNDS

#10513
20100291206
2010-11-18

ORAL DOSAGE FORM

#10514
20100291204
2010-11-18

COMBINATION OF A LONG-ACTING HYPNOTIC AGENT AND A SHORT-ACTING HYPNOTIC AGENT AND THERAPEUTIC USE THEREOF

#10515
20100291203
2010-11-18

Opioid agonist/antagonist combinations

#10516
20100291190
2010-11-18

Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use

#10517
20100291168
2010-11-18

ANTIMICROBIAL FORMULATIONS COMPRISING A COMBINATION OF A PYRIDINE THIOL AND A BIS-QUINOLINIUM SALT

#10518
20100291157
2010-11-18

Composition for headache treatment

#10519
20100291113
2010-11-18

Treatment of Proliferative Disorders Using Antibodies to PSMA

#10520
20100291111
2010-11-18

Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation

#10521
20100291098
2010-11-18

Diabetic nephropathy therapies

#10522
20100291094
2010-11-18

Antibodies that bind to 238P1B2

#10523
20100291087
2010-11-18

Method of treating fibrproliferative disorders

#10524
20100291085
2010-11-18

Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses

#10525
20100291064
2010-11-18

Compounds and methods for the treatment of vascular disease

#10526
20100291058
2010-11-18

Sealants for Skin and Other Tissues

#10527
20100291057
2010-11-18

Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy

#10528
20100291056
2010-11-18

Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same

#10529
20100291053
2010-11-18

Inflammatory Disease Treatment

#10530
20100291050
2010-11-18

Nutritional compositions for reducing oxidative damage

#10531
20100291034
2010-11-18

COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO

#10532
20100291030
2010-11-18

Use of IL-28 and IL-29 to treat cancer and autoimmune disorders

#10533
20100291025
2010-11-18

INDAZOLE INHIBITORS OF TYROSINE KINASE

#10534
20100291024
2010-11-18

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES

#10535
20100291019
2010-11-18

Methods of using ophthalmic compositions comprising povidone-iodine

#10536
20100291007
2010-11-18

Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase

#10537
20100291002
2010-11-18

Dermatologic compositions comprising pyrrolidone-5-carboxylic acid and at least one entity chosen from citrulline, arginine and asparagine, and uses thereof in the treatment of atopic dermatitis

#10538
20100291000
2010-11-18

Diagnostic value of systemic ACE pathway activation in the detection by fluorescence of localized pathological lesions

#10539
20100290994
2010-11-18

O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders

#10540
20100288665
2010-11-18

THERAPEUTIC FORMULATIONS FOR THE TREATMENT OF COLD AND FLU-LIKE SYMPTOMS

#10541
20100286762
2010-11-11

Compositions and Methods for Ameliorating Clinical Electrical Disturbances

#10542
20100286751
2010-11-11

GAS MIST PRESSURE BATH DEVICE

#10543
20100286750
2010-11-11

Gas mist pressure bath device

#10544
20100286595
2010-11-11

Gas mist pressure bath device

#10545
20100286589
2010-11-11

Atherosclerotic Plaque Dissolution Composition

#10546
20100286272
2010-11-11

Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications

#10547
20100286269
2010-11-11

Medium-chain length fatty acids and glycerides as nephroprotection agents

#10548
20100286264
2010-11-11

COMPOSITION COMPRISING A NITROOXYDERIVATIVE OF ACETAMINOPHEN AND A ANTICONVULSANT DRUG FOR THE TREATMENT OF NEUROPATHIC PAIN

#10549
20100286260
2010-11-11

MILNACIPRAN FORMULATIONS

#10550
20100286256
2010-11-11

Compositions and methods for therapy for diseases characterized by defective chloride transport

#10551
20100286226
2010-11-11

COMBINATION THERAPY RELATED TO SEROTONIN DUAL ACTION COMPOUNDS

#10552
20100286222
2010-11-11

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

#10553
20100286200
2010-11-11

COMBINATION OF METFORMIN AND AN MTP INHIBITOR

#10554
20100286172
2010-11-11

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

#10555
20100286168
2010-11-11

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

#10556
20100286154
2010-11-11

ANTIHELMINTIC PASTE

#10557
20100286153
2010-11-11

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

#10558
20100286124
2010-11-11

PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B

#10559
20100286111
2010-11-11

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

#10560
20100286101
2010-11-11

PHARMACEUTICAL COMPOSITION INCLUDING A CORTICOSTEROID AND A VITAMIN D ANALOG HAVING IMPROVED STABILITY

#10561
20100286099
2010-11-11

Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine

#10562
20100286090
2010-11-11

Treatment of Multiple Myeloma

#10563
20100286087
2010-11-11

Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases

#10564
20100286086
2010-11-11

Composition for the treatment of osteoarthritis

#10565
20100286078
2010-11-11

Topical ophthalmic compositions containing tobramycin and dexamethasone

#10566
20100286065
2010-11-11

Topical methods and compositions for the treatment of eye diseases and conditions

#10567
20100286063
2010-11-11

GNRH agonist combination drugs

#10568
20100286050
2010-11-11

Method of preventing progression of hypertension-induced heart failure with PKC peptides

#10569
20100286047
2010-11-11

Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders

#10570
20100286043
2010-11-11

USE OF NEUREGULIN-1 IN REDUCING BRAIN DAMAGE

#10571
20100286039
2010-11-11

Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders

#10572
20100286038
2010-11-11

FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME

#10573
20100286032
2010-11-11

Prodrugs of HIV protease inhibitors

#10574
20100286029
2010-11-11

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#10575
20100286028
2010-11-11

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#10576
20100286023
2010-11-11

Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly

#10577
20100286010
2010-11-11

Ophthalmic Compositions with Hyaluronic Acid

#10578
20100285495
2010-11-11

Methods for identifying GLP-1 secretagogues

#10579
20100285494
2010-11-11

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

#10580
20100285162
2010-11-11

HERBAL COMPOSITION FOR MAINTAINING/CARING THE SKIN AROUND THE EYE, METHODS OF PREPARING THE SAME AND USES THEREOF

#10581
20100285161
2010-11-11

Herbal composition for maintaining/caring the skin around the eye, methods of preparing the same and uses thereof

#10582
20100285159
2010-11-11

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

#10583
20100285150
2010-11-11

DENTAL STERILIZING WATER, METHOD FOR PRODUCING THE WATER, AND DEVICE FOR PRODUCING THE WATER

#10584
20100285138
2010-11-11

Compositions comprising nanoparticles and apoptotic agents and methods of use

#10585
20100285134
2010-11-11

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES

#10586
20100285129
2010-11-11

Agent for salting out active principles in dressings containing at least one of fatty substance

#10587
20100285122
2010-11-11

TABLETS FOR COMBINATION THERAPY

#10588
20100285117
2010-11-11

Combination of triazine derivatives and insulin sensitisers

#10589
20100285115
2010-11-11

Novel Antiretroviral Combination

#10590
20100285097
2010-11-11

VAGINAL DELIVERY SYSTEM

#10591
20100285093
2010-11-11

Methods and compositions for repair of cartilage using an in vivo bioreactor

#10592
20100285092
2010-11-11

Methods and compositions for repair of cartilage using an in vivo bioreactor

#10593
20100285091
2010-11-11

Methods and compositions for repair of cartilage using an in vivo bioreactor

#10594
20100285090
2010-11-11

Methods and compositions for repair of cartilage using an in vivo bioreactor

#10595
20100285089
2010-11-11

Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon

#10596
20100285080
2010-11-11

Cosmetic treatment system and methods

#10597
20100285073
2010-11-11

Micro-RNA family that modulates fibrosis and uses thereof

#10598
20100285053
2010-11-11

Immunosuppressive Extract Of Cordyceps Sinensis And Uses Thereof

#10599
20100285048
2010-11-11

Use of flagellin in the immunotherapy of

#10600
20100285044
2010-11-11

METHOD AND COMPOSITIONS FOR TREATMENT OF CANCERS

#10601
20100285029
2010-11-11

Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies

#10602
20100285028
2010-11-11

Methods of treating coagulopathy

#10603
20100285020
2010-11-11

Leukemic cell CNS infiltration controlled by notch-induced chemotaxis

#10604
20100285013
2010-11-11

PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof

#10605
20100285012
2010-11-11

Methods and compositions for the treatment of cancers and pathogenic infections

#10606
20100285008
2010-11-11

Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis

#10607
20100285000
2010-11-11

USE OF VEGFR-2 INHIBITORS FOR TREATING METASTATIC CANCER

#10608
20100284994
2010-11-11

Use of EDTA and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases

#10609
20100284986
2010-11-11

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MIGRAINES

#10610
20100284982
2010-11-11

Erythrocyte-encapsulated L-asparaginase for enhanced acute lymphoblastic leukemia therapy

#10611
20100284972
2010-11-11

Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans

#10612
20100284969
2010-11-11

Methods and Compositions for Delivery of Medicaments to the Lungs

#10613
20100284968
2010-11-11

Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases

#10614
20100284958
2010-11-11

BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy

#10615
20100284951
2010-11-11

Novel compositions for the treatment of wounds and skin care

#10616
20100284919
2010-11-11

Injectable Radio-Opaque Compositions for Tissue Augmentation

#10617
20100280132
2010-11-04

Method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials

#10618
20100280129
2010-11-04

Method of treating pain caused by inflammation

#10619
20100280126
2010-11-04

Method of inhibiting inflammatory pain

#10620
20100280106
2010-11-04

Oral composition to reduce cold symptoms and duration of same

#10621
20100280101
2010-11-04

Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method

#10622
20100280069
2010-11-04

Controlled release local anesthetic for post dental surgery and method of use

#10623
20100280059
2010-11-04

COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS

#10624
20100280046
2010-11-04

Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions

#10625
20100280041
2010-11-04

RHOKINASE-DEPENDENT INHIBITION ACTIVITY ON PULMONARY ARTERY ENDOTHELIUM DYSFUNCTION, MEDIAL WALL THICKNESS AND VASCULAR OBSTRUCTION OF PULMODIL AND PULMODIL-1

#10626
20100280039
2010-11-04

PHARMACEUTICAL COMPOSITIONS COMPRISING CHLOROPHENYL PIPERAZINE DERIVED COMPOUNDS AND USE OF THE COMPOUNDS IN PRODUCING MEDICAMENTS

#10627
20100280017
2010-11-04

Combination of selected analgesics and COX-II inhibitors

#10628
20100280003
2010-11-04

COMBINATIONS OF JAK INHIBITORS

#10629
20100279987
2010-11-04

COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF

#10630
20100279984
2010-11-04

PHARMACEUTICAL COMPOSITIONS CONTAINING BENFOTIAMINE AND ONE OR ONE MORE PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF PAIN CONDITIONS OF NEUROPATHIC ORIGIN

#10631
20100279981
2010-11-04

Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

#10632
20100279977
2010-11-04

Compositions and methods for treating cancer

#10633
20100279976
2010-11-04

USE OF ARTEMISININ AND ITS DERIVATIVES IN CANCER THERAPY

#10634
20100279967
2010-11-04

Compositions and methods for treating cancer

#10635
20100279959
2010-11-04

Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors

#10636
20100279935
2010-11-04

Oxytocin and melatonin compositions and associated methods for inducing labor

#10637
20100279934
2010-11-04

TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES

#10638
20100279927
2010-11-04

Method of treating a disease or condition characterized by aberrant epithelial cell proliferation

#10639
20100279921
2010-11-04

IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS

#10640
20100279407
2010-11-04

Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines

#10641
20100278997
2010-11-04

Preparation for restenosis prevention

#10642
20100278949
2010-11-04

PRE-PROCEDURE MEAL REGIMEN

#10643
20100278947
2010-11-04

Methods for modulating eicosanoid metabolism

#10644
20100278939
2010-11-04

Treating male infertility secondary to sperm oxidative stress

#10645
20100278936
2010-11-04

Composition for treating skin lesions

#10646
20100278935
2010-11-04

Immune System Modulator Formulation

#10647
20100278915
2010-11-04

COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS

#10648
20100278909
2010-11-04

PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS

#10649
20100278885
2010-11-04

C70-containing liposome, method for producing the same, and use of the same

#10650
20100278875
2010-11-04

PROSTAGLANDIN E2 (PGE2) AS AN ADJUVANT IN MONOCLONAL ANTIBODY GENERATION

#10651
20100278871
2010-11-04

Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein

#10652
20100278856
2010-11-04

Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy

#10653
20100278841
2010-11-04

Down-regulation of mortalin by siRNA

#10654
20100278828
2010-11-04

Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases

#10655
20100278824
2010-11-04

COMBINATIONS COMPRISING GEMCITABINE AND TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER

#10656
20100278805
2010-11-04

Compositions for inhibiting atherosclerosis

#10657
20100278799
2010-11-04

Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly

#10658
20100278781
2010-11-04

Nutrition with non-viable and non-digestible oligosaccharide

#10659
20100278779
2010-11-04

Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine

#10660
20100278778
2010-11-04

Method for bone marrow preservation or recovery

#10661
20100278777
2010-11-04

Method for treating deficiency in hematopoiesis

#10662
20100278744
2010-11-04

Preparation for restenosis prevention

#10663
20100278743
2010-11-04

Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling

#10664
20100274176
2010-10-28

Wound care system and bactericidal methods and devices

#10665
20100273880
2010-10-28

STORAGE-STABLE AQUEOUS COMPOSITION COMPRISING A MAGNESIUM COMPOUND AND L-CARNITINE

#10666
20100273878
2010-10-28

Preventive or therapeutic drug for Alzheimer-type dementia

#10667
20100273876
2010-10-28

ANTIBACTERIAL FORMULATION COMPRISING A DIALKYL SULPHOSUCCINATE AND A CARBANILIDE ANTIBACTERIAL AGENT

#10668
20100273869
2010-10-28

Anti-cancer tocotrienol analogues and associated methods

#10669
20100273867
2010-10-28

THERAPY-ENHANCING GLUCAN

#10670
20100273834
2010-10-28

TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS INCLUDING UREA

#10671
20100273829
2010-10-28

Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal

#10672
20100273810
2010-10-28

METHOD OF TREATING COGNITIVE IMPAIRMENTS AND SCHIZOPHRENIAS

#10673
20100273805
2010-10-28

SULPHIDE BRIDGED DERIVATIVES AS MODULATORS OF MGLUR5 733

#10674
20100273776
2010-10-28

INHIBITION OF ALPHA-SYNUCLEIN TOXICITY

#10675
20100273756
2010-10-28

ADJUNCTIVE FORMULATION AND METHODS FOR PALLIATION OF FINE WRINKLES, MOTTLED HYPERPIGMENTATION, TACTILE ROUGHNESS OF FACIAL SKIN AND RELATED DISORDERS

#10676
20100273752
2010-10-28

MEQUITAZINE FOR TREATING OR PREVENTING PATHOLOGIES INVOLVING HISTAMINE H4 RECEPTORS

#10677
20100273750
2010-10-28

SEROTONIN RECEPTOR ANTAGONISTS FOR TREATING ARTHRITIS

#10678
20100273748
2010-10-28

ANTIMICROBIAL THERAPY

#10679
20100273735
2010-10-28

Soluble, highly branched glucose polymers for enteral and parenteral nutrition and for peritoneal dialysis

#10680
20100273733
2010-10-28

HIV Treatment

#10681
20100273732
2010-10-28

COMBINATION METHODS OF TREATING CANCER

#10682
20100273731
2010-10-28

Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer

#10683
20100273729
2010-10-28

Compositions comprising compounds of natural origin for damaged skin

#10684
20100273709
2010-10-28

Composition Comprising Desmopressin

#10685
20100273703
2010-10-28

Co-Therapy For Diabetic Conditions

#10686
20100273701
2010-10-28

USE OF SALUSIN BETA ALONE OR IN COMBINATION WITH OCTREOTIDE AS A THERAPEUTIC AGENT

#10687
20100273700
2010-10-28

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#10688
20100272833
2010-10-28

Topical compositions for anti-aging and methods of using same

#10689
20100272832
2010-10-28

Topical compositions for anti-aging and methods of using same

#10690
20100272824
2010-10-28

COMPOSITIONS AND METHODS FOR PREVENTING AND MONITORING DISEASE

#10691
20100272816
2010-10-28

MICROCAPSULES COMPRISING LIVER CELLS AND ERYTHROPOIETIN, METHODS FOR PREPARING SAID MICROCAPSULES AND METHODS FOR TREATING A PATIENT COMPRISING APPLYING SAID MICROCAPSULES TO THE PATIENT

#10692
20100272802
2010-10-28

COMPOSITIONS COMPRISING STRONTIUM AND USES THEREOF IN THE TREATMENT OR PREVENTION OF GINGIVITIS, PERIODONTITIS, PERIODONTITIS AS A MANIFESTATION OF SYSTEMIC DISEASES, AND NECROTIZING PERIODONTAL DISEASES

#10693
20100272801
2010-10-28

Pharmaceutical compositions of amlodipine and valsartan

#10694
20100272797
2010-10-28

Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid

#10695
20100272772
2010-10-28

Apparatus, system, and method for creating immunologically enhanced spaces in-vivo

#10696
20100272764
2010-10-28

Microencapsulated compositions and methods for tissue mineralization

#10697
20100272736
2010-10-28

COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION

#10698
20100272732
2010-10-28

EMP2 antibodies and their therapeutic uses

#10699
20100272727
2010-10-28

Method for treating a disease characterized by reduced appetite

#10700
20100272717
2010-10-28

COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER

#10701
20100272711
2010-10-28

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES

#10702
20100272708
2010-10-28

METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY

#10703
20100272703
2010-10-28

IRON FORTIFICATION MUTRITIONAL BLEND

#10704
20100272684
2010-10-28

Hyperbaric treatment in wound healing

#10705
20100272682
2010-10-28

METHOD FOR IMPROVING PHARMACOKINETICS

#10706
20100272678
2010-10-28

Anti-cancer drugs, and uses relating for malignant melanoma and other cancers

#10707
20100272671
2010-10-28

Co-Therapy For Diabetic Conditions

#10708
20100272646
2010-10-28

Method for inducing lymphoid tissue and modulating intestinal homeostasis

#10709
20100272645
2010-10-28

Myocardial perfusion imaging method

#10710
20100272636
2010-10-28

Anti-CD74 immunoconjugates and methods of use

#10711
20100271999
2010-10-28

Relay link HARQ operation

#10712
20100269825
2010-10-28

INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID

#10713
20100268329
2010-10-21

Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease

#10714
20100267924
2010-10-21

Phosphorus-containing compounds with polymeric chains, and methods of making and using the same

#10715
20100267847
2010-10-21

Method of improving sweetness qualities of stevia extract

#10716
20100267831
2010-10-21

Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People

#10717
20100267815
2010-10-21

PFKFB4 inhibitors and methods of using the same

#10718
20100267777
2010-10-21

Treatment of cancers with acquired resistance to kit inhibitors

#10719
20100267772
2010-10-21

Combination of a Serotonin Reuptake Inhibitor and Agomelatine

#10720
20100267765
2010-10-21

Pharmaceutical Compositions and Methods for CCR5 Antagonists

#10721
20100267760
2010-10-21

Methods of and Combination Therapies for Treating or Delaying the Onset of Dyskinesia

#10722
20100267758
2010-10-21

PHARMACEUTICAL FORMULATION

#10723
20100267742
2010-10-21

COMBINATION TARGETED THERAPY FOR LUNG CANCER

#10724
20100267739
2010-10-21

TREATMENT OF AFFECTIVE DISORDERS BY THE COMBINED ACTION OF A NICOTINIC RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE

#10725
20100267736
2010-10-21

METHODS AND COMPOSITIONS TO ENHANCE THE EFFICACY OF PHOSPHODIESTERASE INHIBITORS

#10726
20100267735
2010-10-21

METHODS AND COMPOSITIONS TO ENHANCE THE EFFICACY OF PHOSPHODIESTERASE INHIBITORS

#10727
20100267733
2010-10-21

Synergistic Modulation of Microglial Activation by Nicotine and THC

#10728
20100267691
2010-10-21

Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline

#10729
20100267685
2010-10-21

Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones

#10730
20100267682
2010-10-21

CORTICOSTEROIDS TO TREAT EPOTHILONE OR EPOTHILONE DERIVATIVE INDUCED DIARRHEA

#10731
20100267661
2010-10-21

BETA GLUCANS AND METHODS OF USE THEREOF

#10732
20100267656
2010-10-21

Myeloid differentiation inducing agents

#10733
20100267654
2010-10-21

Rifamycin derivatives

#10734
20100267643
2010-10-21

Chemosensory receptor ligand-based therapies

#10735
20100267640
2010-10-21

Method of Attenuating Neurogenic Swelling or Neurogenic Inflammation

#10736
20100267639
2010-10-21

TREATMENT OF OSTEOARTHRITIS

#10737
20100267637
2010-10-21

TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR

#10738
20100267636
2010-10-21

USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPY

#10739
20100267635
2010-10-21

USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY

#10740
20100267629
2010-10-21

Enterostatin as Therapeutic Agent for Hypoglycemia

#10741
20100267620
2010-10-21

METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE

#10742
20100267618
2010-10-21

Methods for treating congestive heart failure

#10743
20100266715
2010-10-21

COMPOSITION FOR TREATING AIDS AND ASSOCIATED CONDITIONS

#10744
20100266712
2010-10-21

Prevention of Acute Kidney Injury

#10745
20100266711
2010-10-21

THIENOBENZODIAZEPINE MODULATORS OF D1 RECEPTOR, D2 RECEPTOR, AND/OR 5-HT2 RECEPTOR

#10746
20100266709
2010-10-21

Compositions and Methods for Treating Burns

#10747
20100266706
2010-10-21

ORAL PARTICULATE ANTITUMOR PREPARATION

#10748
20100266705
2010-10-21

NANOPARTICULATE MEGESTROL FORMULATIONS

#10749
20100266699
2010-10-21

Pharmaceutical Suspensions and Related Methods

#10750
20100266698
2010-10-21

USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS

#10751
20100266693
2010-10-21

Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix

#10752
20100266692
2010-10-21

NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN ANIONIC CELLULOSIC POLYMER

#10753
20100266691
2010-10-21

Agents and Methods to Stimulate Bone Healing

#10754
20100266681
2010-10-21

FATTY ACID ALCOHOLS

#10755
20100266645
2010-10-21

PHARMACEUTICAL COMPOSITIONS

#10756
20100266628
2010-10-21

Macrocyclic lactone combination compositions, vaccines and methods for producing same

#10757
20100266622
2010-10-21

Prevention and treatment of ocular side effects with a cyclosporin

#10758
20100266595
2010-10-21

TREATMENT OF INSULIN-RESISTANT DISORDERS

#10759
20100266591
2010-10-21

METHOD OF TREATING ERYTHROPOIETIN HYPORESPONSIVE ANEMIAS

#10760
20100266590
2010-10-21

COMBINATION THERAPY

#10761
20100266584
2010-10-21

Antibodies against the ectodomain of ErbB3 and uses thereof

#10762
20100266581
2010-10-21

COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTHIONE REDUCTASE

#10763
20100266573
2010-10-21

METHOD AND MEANS FOR OBTAINING BRONCHORELAXATION

#10764
20100266569
2010-10-21

PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN

#10765
20100266567
2010-10-21

USE OF URATE OXIDASE FOR THE TREATMENT OR PROPHYLAXIS OF DISORDERS OR INDIRECT SEQUELAE OF THE HEART CAUSED BY ISCHEMIC OR REPERFUSION EVENTS

#10766
20100266566
2010-10-21

Treatments involving glutaredoxins and similar agents

#10767
20100266557
2010-10-21

Peptide-based scaffolds for cartilage regeneration and methods for their use

#10768
20100266543
2010-10-21

Linked dibenzimidazole antivirals

#10769
20100266540
2010-10-21

AG-205 for the treatment of breast cancer

#10770
20100266531
2010-10-21

IL-17 binding proteins

#10771
20100266515
2010-10-21

Treatment of malodour

#10772
20100266511
2010-10-21

PHARMACEUTICAL FOAM

#10773
20100266501
2010-10-21

METHODS AND COMPOSITIONS FOR ORGAN PROTECTION

#10774
20100266496
2010-10-21

Anti-CD74 immunoconjugates and methods of use

#10775
20100266495
2010-10-21

Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody

#10776
20100264055
2010-10-21

Portable powder delivery system and method

#10777
20100261785
2010-10-14

Compositions containing sesamin-class compound(s) and arachidonic acid class compound(s)

#10778
20100261784
2010-10-14

AGENT FOR REDUCING INTESTINAL TOXIC BACTERIUM AND FOOD OR PHARMACEUTICAL PREPARATION COMPRISING THE SAME

#10779
20100261779
2010-10-14

Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity

#10780
20100261771
2010-10-14

Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof

#10781
20100261770
2010-10-14

PHARMACEUTICAL COMPOSITION FOR IMPROVING LOWER URINARY TRACT SYMPTOMS

#10782
20100261752
2010-10-14

5-HTreceptor agonist compounds for treatment of cognitive disorders

#10783
20100261748
2010-10-14

STABLE LORATADINE SPILL RESISTANT FORMULATION

#10784
20100261746
2010-10-14

PHARMACEUTICAL FORMULATION

#10785
20100261745
2010-10-14

PHARMACEUTICAL FORMULATION

#10786
20100261744
2010-10-14

Stable methylnaltrexone preparation

#10787
20100261731
2010-10-14

Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate

#10788
20100261726
2010-10-14

TREATMENT OF AML

#10789
20100261699
2010-10-14

N-PYRAZOLE-2-PYRIDINE CARBOXAMIDE DERIVATIVE

#10790
20100261698
2010-10-14

Organic compounds

#10791
20100261695
2010-10-14

TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS

#10792
20100261690
2010-10-14

NOVEL COMBINATIONS

#10793
20100261688
2010-10-14

Stabilization of oily suspensions comprising hydrophobic silicas

#10794
20100261686
2010-10-14

Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction

#10795
20100261684
2010-10-14

Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction

#10796
20100261672
2010-10-14

Pharmaceutical compositions of pyrimidine-2,4,6-triones

#10797
20100261670
2010-10-14

COMPLEXES OF PHOSPHATE DERIVATIVES

#10798
20100261669
2010-10-14

Unit dosage for brain health

#10799
20100261663
2010-10-14

Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof

#10800
20100261152
2010-10-14

Method for expansion of stem cells